Union Health Minister Harsh Vardhan Launches COVID-19 Vaccine portal

by amolwarankar
0 comment

New Delhi : Since the pandemic started there are attempts to make coronavirus vaccine. The government has launched an online portal for the COVID19 vaccine were everyone will be able to look-up all contemporary research-development & clinical trials related information. It is a clinical Registry portal for information and updates on the various Covid-19 vaccine being produced in the country stated Harsh Vardhan, Union Health Minister.

In a tweet Union Minister, Harsh Vardhan said, ‘Today’s a historic day for ICMR. It’s an honour for me to release 100-year timeline of history of ICMR within its premises today. The contribution of scientists associated with it is commemorated & serves as an inspiration to upcoming scientists’.

On dynamics of transparent information on the status of vaccine development, he emphasized, “The portal provides useful and important information related to vaccine development, ongoing clinical trials and progress made in this area locally and globally at regular intervals. Today, in the times of COVID, vaccine development is watched very closely. Thus, it becomes important to showcase the status of vaccine development in the country.”

The two online portals hosted by Indian Council of Medical Research (ICMR) site will contain all the information related to vaccine, from progress to its usage. Earlier reports suggest that in the first stage, the ICMR vaccine portal will reflect the information on Covid-19 vaccine development in India.

Meanwhile, the phase-III or the last stage of clinical trial of the COVID-19 vaccine ‘Covishield’, being developed by Oxford University, and manufactured by the Serum Institute of India (SII). The Covishield vaccine will be administered as a dose to 150 to 200 volunteers, as per the reports.

Vaccine developers Bharat Biotech International Ltd. are at the second-phase human trial stage and Zydus Cadila is in the process to receive approvals for conducting third-phase clinical trials. The Uttar Pradesh government announced that phase-3 trial of the coronavirus vaccine ‘COVAXIN’ will start in Lucknow and Gorakhpur from October.

The Serum’s CEO Adar Poonawalla calling the distribution of a COVID-19 vaccine to 1.3 billion population of India asked government do they have ₹80,000 crore over the next one year for distribution of COVID-19 vaccine to every person in India.

Related Posts